Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Role of commensal bacteria in helminth-mediated immunoregulation of chronic inflammation
EF 2015-16
Résumé
Rheumatoid arthritis (RA) is an autoimmune disease characterized by debilitating joint inflammation. RA places a significant burden on the quality of life of those affected and on Canadian health care system costs. Recent RA clinical trials have used intestinal worms as a therapeutic. During these trials the patients that received worms, remarkably, had improved RA symptoms and remission rates. Our intestines are colonized with trillions of “friendly” bacteria (known as commensal bacteria) that provide us with many benefits, including protecting us from infection and supporting a healthy immune system. It is theorized that these worms improve RA symptoms by restoring commensal bacterial communities, which in turn improves the inflammatory state of our immune system. However, this hypothesis has yet to be investigated. We are interested in determining how commensal bacteria and intestinal worms interact to change the immune status of RA patients to ameliorate their symptoms. I propose to test the hypothesis that symptomatic relief of RA can be achieved through the worm's ability to restore healthy populations of bacteria. We anticipate that this research will increase our understanding of the mechanisms by which intestinal bacteria and worms interact with the immune system. This is an innovative area of investigation and findings from this study might influence a novel direction in RA therapy development. There is tremendous opportunity for these therapies to be more successful and cost-effective than current RA treatments and they could dramatically improve the quality of life and care for Canadians suffering with rheumatoid arthritis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
349863
Name
Filyk Heather
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of commensal bacteria in helminth-mediated immunoregulation of chronic inflammation
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Inflammatory Diseases; Flow Cytometry; Germ-Free And Gnotobiotic Mice; Helminth Parasites; Immunotherapy; In Vivo Mouse Models Of Human Disease; Microbiota; Rheumatoid Arthritis
Abstract
Rheumatoid arthritis (RA) is an autoimmune disease characterized by debilitating joint inflammation. RA places a significant burden on the quality of life of those affected and on Canadian health care system costs. Recent RA clinical trials have used intestinal worms as a therapeutic. During these trials the patients that received worms, remarkably, had improved RA symptoms and remission rates. Our intestines are colonized with trillions of “friendly” bacteria (known as commensal bacteria) that provide us with many benefits, including protecting us from infection and supporting a healthy immune system. It is theorized that these worms improve RA symptoms by restoring commensal bacterial communities, which in turn improves the inflammatory state of our immune system. However, this hypothesis has yet to be investigated. We are interested in determining how commensal bacteria and intestinal worms interact to change the immune status of RA patients to ameliorate their symptoms. I propose to test the hypothesis that symptomatic relief of RA can be achieved through the worm's ability to restore healthy populations of bacteria. We anticipate that this research will increase our understanding of the mechanisms by which intestinal bacteria and worms interact with the immune system. This is an innovative area of investigation and findings from this study might influence a novel direction in RA therapy development. There is tremendous opportunity for these therapies to be more successful and cost-effective than current RA treatments and they could dramatically improve the quality of life and care for Canadians suffering with rheumatoid arthritis.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Filyk, Heather
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~